SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-21-005394
Filing Date
2021-04-30
Accepted
2021-04-30 16:03:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tgtx-20210430xdefa14a.htm DEFA14A 17631
2 GRAPHIC tgtx-20210430xdefa14a002.jpg GRAPHIC 115517
3 GRAPHIC tgtx-20210430xdefa14a001.jpg GRAPHIC 139493
  Complete submission text file 0001558370-21-005394.txt   370363
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32639 | Film No.: 21877720
SIC: 2834 Pharmaceutical Preparations